TABLE 2.
MICs of β-lactams for A. caviae A324R, the transformant E. coli DH5α(pJDB2), the recombinant E. coli DH5α(pIP19), and E.coli DH5α
| β-lactam | MIC (μg/ml) for:
|
|||
|---|---|---|---|---|
| A. caviae A324R | E. coli DH5α(pJDB2) | E. coli DH5α(pIP19) | E. coli DH5α | |
| Ticarcillin | 2,048 | 512 | 1,024 | 4 |
| Piperacillin | 256 | 8 | 2 | 1 |
| Cefazoline | 512 | 256 | 512 | 2 |
| Cefoxitin | 1,024 | 128 | 512 | 4 |
| Aztreonam | 8 | 0.25 | 0.25 | 0.25 |
| Ceftazidime | 1,024 | 256 | 512 | ≤1 |
| Clavulanatea | 512 | 256 | 256 | ≤1 |
| Tazobactama | 1,024 | 256 | 256 | ≤1 |
| Imipenem | 16 | 4 | 8 | 0.5 |
| Meropenem | 1 | 0.5 | 0.5 | ≤0.25 |
a
Clavulanate and tazobactam were used at 2 and 4 μg/ml, respectively.